Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation

Fertility and Sterility

Volumn 98, Issue 5, 2012, Pages

  Blumenfeld, Zeev ^a   Patel, Biren ^a   Leiba, Ronit ^a   Zuckerman, Tsila ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Fertility preservation; GnRH agonist; gonadotoxicity; premature ovarian failure (POF); stem cell transplantation (SCT)

Indexed keywords

AZATHIOPRINE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; GONADORELIN AGONIST; HYDROXYUREA; MELPHALAN; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY; TRIPTORELIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST CANCER; CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OVARY FUNCTION; PATIENT SELECTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

EID: 84867746693     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.07.1144     Document Type: Article

References (21)

1. E.S. Georgescu, J.M. Goldberg, S.S. du Plessis, and A. Agarwal Present and future fertility preservation strategies for female cancer patients Obstet Gynecol Surv 63 2008 725 732
2. A. Jemal, F. Bray, M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. J. Blatt Pregnancy outcome in long-term survivors of childhood cancer Med Pediatr Oncol 33 1999 29 33
4. W.H.B. Wallace, R.A. Anderson, and D.S. Irvine Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 6 2005 209 218
5. R.A. Lobo Potential options for preservation of fertility in women N Engl J Med 353 2005 64 73
6. Z. Blumenfeld Debate: how to preserve fertility in young women exposed to chemotherapy? The role of GnRH-agonist in addition to cryopreservation of embryos, oocytes, or ovaries Oncologist 12 2007 1044 1054
7. Z. Blumenfeld, and M. von Wolff GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy Hum Reprod Update 14 2008 543 552
8. Z. Blumenfeld, I. Avivi, A. Eckman, R. Epelbaum, J.M. Rowe, and E.J. Dann Gonadotropin releasing hormone agonist decreases chemotherapy induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma Fertil Steril 89 2008 166 173
9. Z. Blumenfeld GnRH-agonists in fertility preservation Curr Opin Endocrinol Diabet Obes 15 2008 523 528
10. Z. Blumenfeld, and T. Zuckerman Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist Oncologist 15 2010 59 60
11. Y.C. Cheng, M. Takagi, A. Milbourne, R.E. Champlin, and N.T. Ueno Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients Oncologist 17 2012 233 238
12. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertil Steril 91 2009 694 697
13. A. Sverrisdottir, M. Nystedt, H. Johansson, and T. Fornander Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial Breast Cancer Res Treat 117 2009 561 567
14. L. Del Mastro, L. Boni, A. Michelotti, T. Gamucci, N. Olmeo, and S. Gori Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial JAMA 306 2011 269 276
15. K. Ataya, L.V. Rao, E. Lawrence, and R. Kimmel Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys Biol Reprod 52 1995 365 372
16. M.E. Clowse, M.A. Behera, C.K. Anders, S. Copland, C.J. Coffman, and P.C. Leppert Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis J Womens Health (Larchmt) 18 2009 311 319
17. I. Ben-Aharon, A. Gafter-Gvili, L. Leibovici, and S.M. Stemmer Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis Breast Cancer Res Treat 122 2010 803 811
18. S.S. Kim, J.R. Lee, B.C. Jee, C.S. Suh, S.H. Kim, and A. Ting Use of hormonal protection for chemotherapy-induced gonadotoxicity Clin Obstet Gynecol 53 2010 740 752
19. M.A. Bedaiwy, A.M. Abou-Setta, N. Desai, W. Hurd, D. Starks, and S.A. El-Nashar Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis Fertil Steril 95 2011 906 914
20. Z. Blumenfeld Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function Oncologist 17 2012 162 163
21. K. Behringer, I. Thielen, H. Mueller, H. Goergen, A.D. Eibl, and J. Rosenbrock Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial Ann Oncol 23 2012 1818 1825